Through our partnerships, we are helping translate world-class, clinical research into potential patient solutions that may change the course of kidney care.

Collaborator Case Study Example:

University of Michigan

WHY:

University of Michigan has multiple and advanced biomarker hypotheses to better serve the kidney disease patient population but needs a partner with business expertise and processes to help bring it to market.

WHAT:

A new biomarker – uEGF – is being studied at all stages of chronic kidney disease (CKD), even pre-CKD. Will it be highly prognostic in early-stage, chronic kidney disease, allowing for improved kidney health outcomes?